Verified factor-similar pair

DES vs DFSV

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB HML RMW
Similarity score
92
Near substitute

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • DFSV has the higher backtested relative Sharpe (1.275 vs 0.895).
  • DFSV has the lower published fee (0.30% vs 0.38%).
  • DFSV is cheaper on dividend valuation (102 vs 136, where 100 is each fund's historical median).
  • DFSV has the stronger regression fit (adjusted R-squared 0.979 vs 0.941).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

DES

WisdomTree U.S. SmallCap Dividend Fund
SMB HML RMW
Adj. R2
0.941
Rel. Sharpe
0.895
Mkt beta
0.90
AUM
US$2.0B
MER
0.38%
Valuation
136

DFSV

Dimensional US Small Cap Value ETF
SMB HML RMW
Adj. R2
0.979
Rel. Sharpe
1.275
Mkt beta
1.02
AUM
US$7.1B
MER
0.30%
Valuation
102

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
DES
+0.75
|t|
+18.4
DFSV
+0.86
|t|
+15.4
diff -0.11
HML
DES
+0.39
|t|
+9.9
DFSV
+0.44
|t|
+7.7
diff -0.05
RMW
DES
+0.28
|t|
+5.7
DFSV
+0.25
|t|
+4.8
diff +0.02
CMA
DES
+0.10
|t|
+1.6
DFSV
+0.09
|t|
+1.4
diff +0.00
UMD
DES
-0.10
|t|
-4.2
DFSV
-0.08
|t|
-2.2
diff -0.02

Why This Pair Matches

Exposure level
94
Exposure shape
100
Mkt beta diff
0.11
Rel. Sharpe diff
0.381

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

DES fund page DFSV fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.